Cargando…
Removal of MuRF1 Increases Muscle Mass in Nemaline Myopathy Models, but Does Not Provide Functional Benefits
Nemaline myopathy (NM) is characterized by skeletal muscle weakness and atrophy. No curative treatments exist for this debilitating disease. NM is caused by mutations in proteins involved in thin-filament function, turnover, and maintenance. Mutations in nebulin, encoded by NEB, are the most common...
Autores principales: | Lindqvist, Johan, Kolb, Justin, de Winter, Josine, Tonino, Paola, Hourani, Zaynab, Labeit, Siegfried, Ottenheijm, Coen, Granzier, Henk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331820/ https://www.ncbi.nlm.nih.gov/pubmed/35897687 http://dx.doi.org/10.3390/ijms23158113 |
Ejemplares similares
-
Modulation of Muscle Atrophy, Fatigue and MLC Phosphorylation by MuRF1 as Indicated by Hindlimb Suspension Studies on MuRF1-KO Mice
por: Labeit, Siegfried, et al.
Publicado: (2010) -
Sarcomere Dysfunction in Nemaline Myopathy
por: de Winter, Josine M., et al.
Publicado: (2017) -
Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism
por: Lindqvist, Johan, et al.
Publicado: (2020) -
Regulation of Glucose Metabolism by MuRF1 and Treatment of Myopathy in Diabetic Mice with Small Molecules Targeting MuRF1
por: Labeit, Siegfried, et al.
Publicado: (2021) -
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2
por: Witt, Christian C, et al.
Publicado: (2008)